FDA Fast-Tracks AI That Monitors Heart Failure From Home

Heart failure patients could soon monitor their condition from home using the smartwatch already on their wrist, thanks to a breakthrough AI platform that just earned FDA fast-track approval.

Coredio's new software transforms consumer wearables and standard blood pressure cuffs into medical-grade heart monitoring tools. The technology provides doctors with hospital-quality data about how well a patient's heart is pumping, without invasive procedures or clinic visits.

The timing matters because heart failure affects 6.7 million Americans and causes more hospitalizations for seniors than any other condition. Right now, doctors lose track of patients the moment they leave the hospital, often discovering problems only when someone ends up back in the emergency room.

"The most vulnerable period begins when patients leave the hospital," explains Dr. Jagmeet P. Singh from Mass General Brigham. Traditional monitoring requires either invasive catheter procedures or bulky implanted sensors reserved only for the sickest patients.

Coredio's platform works differently. After a one-time setup, patients simply wear their regular smartwatch and use a home blood pressure cuff for quick readings. The AI analyzes the data using a personalized digital model of each patient's cardiovascular system, tracking four key measurements cardiologists use to spot trouble early.

The system earned FDA Breakthrough Device Designation in March 2026, placing it on an accelerated path toward full approval. The designation recognizes technologies that address serious conditions with few existing solutions.

Dr. Farrukh Jafri from White Plains Hospital sees immediate value for the critical weeks after hospital discharge. "This brings hemodynamic-level data into that gap, without requiring invasive devices or additional clinical visits," he says.

The Ripple Effect

Beyond individual patients, this technology could reshape America's most expensive medical problem. Heart failure costs the healthcare system billions annually, largely through preventable hospital readmissions.

Early intervention changes everything. When doctors can spot cardiac decompensation before symptoms become severe, they can adjust medications remotely and keep patients stable at home. Fewer ambulance rides, fewer ER visits, fewer hospitalizations.

The platform works with wearables patients already own, removing cost barriers that often limit access to advanced monitoring. As the technology reaches approval, it could extend specialized cardiac care to rural areas and underserved communities where cardiologists are scarce.

Founded in 2023, Coredio combined physics-based modeling with machine learning trained on real clinical data. The result mimics what doctors previously could only see through invasive catheterization performed on just 10% of heart failure patients.

The company expects to submit its formal FDA application soon, with clinical trials already underway at multiple hospital systems. For millions living with heart failure, relief might soon be as simple as checking your watch.